Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future
- PMID: 27072377
- PMCID: PMC5292013
- DOI: 10.1016/j.pnpbp.2016.03.010
Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future
Abstract
Neuropsychiatric disorders are common health problems affecting approximately 1% of the population. Twin, adoption, and family studies have displayed a strong genetic component for many of these disorders; however, the underlying pathophysiological mechanisms and neural substrates remain largely unknown. Given the critical need for new diagnostic markers and disease-modifying treatments, expanding the focus of genomic studies of neuropsychiatric disorders to include the role of non-coding RNAs (ncRNAs) is of growing interest. Of known types of ncRNAs, microRNAs (miRNAs) are 20-25-nucleotide, single-stranded, molecules that regulate gene expression through post-transcriptional mechanisms and have the potential to coordinately regulate complex regulatory networks. In this review, we summarize the current knowledge on miRNA alteration/dysregulation in neuropsychiatric disorders, with a special emphasis on schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). With an eye toward the future, we also discuss the diagnostic and prognostic potential of miRNAs for neuropsychiatric disorders in the context of personalized treatments and network medicine.
Keywords: Bipolar disorder; MiRNA; Neuroplasticity; Non-coding RNA; Schizophrenia.
Copyright © 2016 Elsevier Inc. All rights reserved.
Figures


References
-
- Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M, Tsuang MX. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005;134B(1):60–66. http://dx.doi.org/10.1002/ajmg.b.30140. - DOI - PubMed
-
- Alural B, Ozerdem A, Allmer J, Gene K, Gene S. Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells. Front Cell. Neurosci. 2015;9:209. http://dx.doi.org/10.3389/fncel.2015.00209. - DOI - PMC - PubMed
-
- Amiel J, Rio M, de Pontual L, Redon R, Malan V, Boddaert N, Colleaux L. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am. J. Hum. Genet. 2007;80(5):988–993. http://dx.doi.org/10.1086/515582. - DOI - PMC - PubMed
-
- Amir RE, Van den Veyver LB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23(2):185–188. http://dx.doi.org/10.1038/13810. - DOI - PubMed
-
- Banigan MG, Kao RE, Kozubek JA, Winslow AR, Medina J, Costa J, Delalle I. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS One. 2013;8(1):e48814. http://dx.doi.org/10.1371/journal.pone.0048814. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous